Annual Operating Profit
$192.03 M
+$71.84 M+59.78%
December 31, 2023
Summary
- As of February 7, 2025, HRMY annual operating income is $192.03 million, with the most recent change of +$71.84 million (+59.78%) on December 31, 2023.
- During the last 3 years, HRMY annual operating profit has risen by +$175.04 million (+1030.52%).
- HRMY annual operating profit is now at all-time high.
Performance
HRMY Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
$61.71 M
+$40.35 M+188.96%
September 30, 2024
Summary
- As of February 7, 2025, HRMY quarterly operating income is $61.71 million, with the most recent change of +$40.35 million (+188.96%) on September 30, 2024.
- Over the past year, HRMY quarterly operating profit has increased by +$21.51 million (+53.52%).
- HRMY quarterly operating profit is now -4.34% below its all-time high of $64.51 million, reached on September 30, 2023.
Performance
HRMY Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
$175.29 M
-$2.80 M-1.57%
September 30, 2024
Summary
- As of February 7, 2025, HRMY TTM operating income is $175.29 million, with the most recent change of -$2.80 million (-1.57%) on September 30, 2024.
- Over the past year, HRMY TTM operating profit has dropped by -$16.73 million (-8.71%).
- HRMY TTM operating profit is now -13.92% below its all-time high of $203.64 million, reached on March 31, 2024.
Performance
HRMY TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
HRMY Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +59.8% | +53.5% | -8.7% |
| 3 y3 years | +1030.5% | +193.1% | +163.0% |
| 5 y5 years | +563.4% | +307.1% | +220.1% |
HRMY Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +119.4% | -4.3% | +418.5% | -13.9% | +100.3% |
| 5 y | 5-year | at high | +231.6% | -4.3% | +283.1% | -13.9% | +220.1% |
| alltime | all time | at high | +231.6% | -4.3% | +197.7% | -13.9% | +220.1% |
Harmony Biosciences Holdings Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $61.71 M(+189.0%) | $175.29 M(-1.6%) |
| Jun 2024 | - | $21.36 M(-59.0%) | $178.09 M(-12.5%) |
| Mar 2024 | - | $52.03 M(+29.4%) | $203.64 M(+6.0%) |
| Dec 2023 | $192.03 M(+59.8%) | $40.20 M(-37.7%) | $192.03 M(-3.7%) |
| Sep 2023 | - | $64.51 M(+37.5%) | $199.45 M(+35.8%) |
| Jun 2023 | - | $46.90 M(+16.0%) | $146.84 M(+10.4%) |
| Mar 2023 | - | $40.42 M(-15.1%) | $133.05 M(+10.7%) |
| Dec 2022 | $120.19 M(+37.3%) | $47.61 M(+300.1%) | $120.19 M(+18.8%) |
| Sep 2022 | - | $11.90 M(-64.1%) | $101.20 M(-8.3%) |
| Jun 2022 | - | $33.12 M(+20.2%) | $110.36 M(+9.8%) |
| Mar 2022 | - | $27.56 M(-3.8%) | $100.55 M(+14.9%) |
| Dec 2021 | $87.53 M | $28.63 M(+36.0%) | $87.53 M(+31.3%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2021 | - | $21.05 M(-9.7%) | $66.66 M(+19.1%) |
| Jun 2021 | - | $23.31 M(+60.4%) | $55.98 M(+40.0%) |
| Mar 2021 | - | $14.53 M(+87.3%) | $39.98 M(+152.4%) |
| Dec 2020 | $16.99 M(-111.6%) | $7.76 M(-25.3%) | $15.84 M(-161.8%) |
| Sep 2020 | - | $10.38 M(+42.0%) | -$25.61 M(-61.1%) |
| Jun 2020 | - | $7.31 M(-176.1%) | -$65.80 M(-28.8%) |
| Mar 2020 | - | -$9.61 M(-71.5%) | -$92.37 M(-36.7%) |
| Dec 2019 | -$145.90 M(+252.1%) | -$33.69 M(+13.0%) | -$145.90 M(+30.0%) |
| Sep 2019 | - | -$29.80 M(+54.7%) | -$112.21 M(+36.2%) |
| Jun 2019 | - | -$19.26 M(-69.5%) | -$82.41 M(+30.5%) |
| Mar 2019 | - | -$63.14 M | -$63.14 M |
| Dec 2018 | -$41.44 M | - | - |
FAQ
- What is Harmony Biosciences Holdings annual operating income?
- What is the all time high annual operating profit for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings annual operating profit year-on-year change?
- What is Harmony Biosciences Holdings quarterly operating income?
- What is the all time high quarterly operating profit for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings quarterly operating profit year-on-year change?
- What is Harmony Biosciences Holdings TTM operating income?
- What is the all time high TTM operating profit for Harmony Biosciences Holdings?
- What is Harmony Biosciences Holdings TTM operating profit year-on-year change?
What is Harmony Biosciences Holdings annual operating income?
The current annual operating profit of HRMY is $192.03 M
What is the all time high annual operating profit for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high annual operating income is $192.03 M
What is Harmony Biosciences Holdings annual operating profit year-on-year change?
Over the past year, HRMY annual operating income has changed by +$71.84 M (+59.78%)
What is Harmony Biosciences Holdings quarterly operating income?
The current quarterly operating profit of HRMY is $61.71 M
What is the all time high quarterly operating profit for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high quarterly operating income is $64.51 M
What is Harmony Biosciences Holdings quarterly operating profit year-on-year change?
Over the past year, HRMY quarterly operating income has changed by +$21.51 M (+53.52%)
What is Harmony Biosciences Holdings TTM operating income?
The current TTM operating profit of HRMY is $175.29 M
What is the all time high TTM operating profit for Harmony Biosciences Holdings?
Harmony Biosciences Holdings all-time high TTM operating income is $203.64 M
What is Harmony Biosciences Holdings TTM operating profit year-on-year change?
Over the past year, HRMY TTM operating income has changed by -$16.73 M (-8.71%)